← Eichor
Condition: Carcinoma Breast Stage I Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Carcinoma Breast Stage I

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SABER Study for Selected Early Stage Breast Cancer
NA · 1 location(s) · University of Miami · NCT04360330Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
Phase 1 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT04778839Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Phase 1 · 29 location(s) · Novartis Pharmaceuticals · NCT06562192A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
Phase 1/Phase 2 · 22 location(s) · Forward Pharmaceuticals Co., Ltd. · NCT06064812A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive
Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT07443943First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 16 location(s) · Tubulis GmbH · NCT06657222Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Phase 2 · 1 location(s) · Mayo Clinic · NCT06635980Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Phase 1 · 1 location(s) · Novartis Pharmaceuticals · NCT07630961Pre Operative Trastuzumab in Operable Breast Cancer
Phase 3 · 1 location(s) · Dr Rajendra A. Badwe · NCT01785420Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT06042569Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
Phase 2 · 7 location(s) · Jonsson Comprehensive Cancer Center · NCT05595499PRE-I-SPY Phase I/Ib Oncology Platform Program
Phase 1 · 7 location(s) · QuantumLeap Healthcare Collaborative · NCT05868226Endoscopy/Robotic Assisted Nipple Skin Sparing Mastectomy
Phase N/A · 1 location(s) · Alejandra García-Novoa · NCT06823414Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagn
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02918474Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemot
Phase 2 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06727773Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Brea
Phase N/A · 5 location(s) · Mayo Clinic · NCT05417867Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06800612Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT06802172Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in
Phase N/A · 1 location(s) · Oncology Institute of Southern Switzerland · NCT04543799A Study of Revaree Plus in People With Breast Cancer
Phase 4 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07042581Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT05874297Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Canc
Phase 1 · 4 location(s) · Emory University · NCT06324240Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatm
Phase 2 · 1 location(s) · University of Washington · NCT04329065A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Phase 1/Phase 2 · 4 location(s) · Cancer Research UK · NCT06380816Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
NA · 2 location(s) · Wake Forest University Health Sciences · NCT07474090Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer
Phase 3 · 18 location(s) · Latin American Cooperative Oncology Group · NCT04540692Capecitabine in ER+/HER2-negative Breast Cancer
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT07631052A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
NA · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT07095114A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Hi
Phase 1/Phase 2 · 3 location(s) · University of Southern California · NCT04333706A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
Phase 1/Phase 2 · 2 location(s) · Memorial Sloan Kettering Cancer Center · NCT05130801
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.